ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model.

Christina Gross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.